Online Exclusive Article

Chemotherapy-Related Cognitive Change: A Principle-Based Concept Analysis

Mary Louise Kanaskie

cognition disorders, cognitive therapy, chemotherapy
ONF 2012, 39(3), E241-E248. DOI: 10.1188/12.ONF.E241-E248

Purpose/Objectives: To present the results of a principle-based concept analysis of cognitive change in patients with cancer following chemotherapy treatment.

Data Sources: 86 English-language articles retrieved through OVID, PubMed, CINAHL®, and Web of Knowledge searches through June 2010. No time limits were imposed.

Data Synthesis: Analysis was based on the philosophical principles: epistemologic, pragmatic, linguistic, and logical. Conceptual components were identified and a theoretical definition of chemotherapy-related cognitive change emerged; the term was not clearly defined or well differentiated in the scientific literature. Implicit meanings are found in patients' subjective accounts, descriptions of the cognitive domains studied, and the choice of neuropsychological assessment instruments. Antecedents relative to chemotherapy-related cognitive change include disease and treatment factors. Moderators may include anxiety, depression, and fatigue. Consequences or outcomes of the experience of chemotherapy-related cognitive change include adjustment to illness, impact on quality of life, and potential for emotional distress.

Conclusions: The principle-based concept analysis generated conceptual insights about chemotherapy-related cognitive change that are based on sound scientific evidence. The product of this method of analysis is a theoretical definition that reflects the state of the science.

Implications for Nursing: When the impact of cognitive change following chemotherapy is better understood, meaningful and timely interventions can be developed to improve quality of life for cancer survivors.

Jump to a section


    Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., … Silberfarb, P. M. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20, 485-493.
    Ahles, T. A., Saykin, A. J., Noll, W. W., Furstenberg, C. T., Guerin, S., Cole, B., & Mott, L. A. (2003). The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psycho-Oncology, 12, 612-619. doi:10.1002/pon.742
    Barsevick, A. M. (2007). The elusive concept of the symptom cluster. Oncology Nursing Forum, 34, 971-980. doi:10.1188/07.ONF.971-980
    Bender, C. M., Paraska, K. K., Sereika, S. M., Ryan, C. M., & Berga, S. L. (2001). Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: A critical review. Journal of Pain and Symptom Management, 21, 407-424.
    Boehmke, M. M., & Dickerson, S. S. (2005). Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities. Cancer Nursing, 28, 382-389.
    Bower, J. E. (2008). Behavioral symptoms in patients with breast cancer and survivors. Journal of Clinical Oncology, 26, 768-777. doi:10.1200/JCO.2007.14.3248
    Boykoff, N., Moieni, M., & Subramanian, S. K. (2009). Confronting chemobrain: An in-depth look at survivors' reports of impact on work, social networks, and health care response. Journal of Cancer Survivorship, 3, 223-232.
    Brezden, C. B., Phillips, K. A., Abdolell, M., Bunston, T., & Tannock, I. F. (2000). Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Journal of Clinical Oncology, 18, 2695-2701.
    Byar, K. L., Berger, A. M., Bakken, S. L., & Cetak, M. A. (2006). Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms and quality of life [Online exclusive]. Oncology Nursing Forum, 33, E18-E26. doi:10.1188/06.ONF.E18.E26
    Castellon, S., & Ganz, P. A. (2009). Neuropsychological studies in breast cancer: In search of chemobrain. Breast Cancer Research and Treatment, 116, 125-127.
    Castellon, S. A., Ganz, P. A., Bower, J. E., Petersen, L., Abraham, L., & Greendale, G. A. (2004). Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. Journal of Clinical and Experimental Neuropsychology, 26, 955-969. doi:10.1080/13803390490510905
    Cimprich, B. (1992). Attentional fatigue following breast cancer surgery. Research and Nursing Health, 15, 199-207. doi:10.1002/nur.4770150306
    Cimprich, B. (1993). Development of an intervention to restore attention in cancer patients. Cancer Nursing, 16, 83-92.
    Cimprich, B. (1995). Symptom management: Loss of concentration. Seminars in Oncology Nursing, 11, 279-288
    Cohen, M. Z., & Armstrong, T. S. (2004). Cognitive dysfunction. In C. H. Yarbro, M. H. Frogge, & M. Goodman (Eds.), Cancer symptom management (pp. 635-647). Sudbury, MA: Jones and Bartlett.
    Collins, B., Mackenzie, J., Stewart, A., Bielajew, C., & Verma, S. (2009). Cognitive effects of hormonal therapy in early stage breast cancer patients: A prospective study. Psycho-Oncology, 18, 811-821. doi:10.1002/pon.1453
    Cull, A., Hay, C., Love, S. B., Mackie, M., Smets, E., & Stewart, M. (1995). What do cancer patients mean when they complain of concentration and memory problems? British Journal of Cancer, 74, 1674-1679.
    Downie, F. P., Mar Fan, H. G., Houede-Tchen, N., Yi, Q., & Tannock, I. F. (2006). Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: Evaluation with patient interview after formal assessment. Psycho-Oncology, 15, 921. doi:10.1002/pon.1035
    Eberhardt, B., Dilger, S., Musial, F., Wedding, U., Weiss, T., & Miltner, W. H. R. (2006). Short term monitoring of cognitive functions before and during the first course of treatment. Journal of Cancer Research and Clinical Oncology, 132, 234-240. doi:10.1007/s00432-005-0070-8
    Evens, K., & Eschiti, V. S. (2009). Cognitive effects of cancer treatment: "Chemo brain" explained. Clinical Journal of Oncology Nursing, 13, 661-666. doi:10.1188/09.CJON.661-666
    Falleti, M. G., Sanfilippo, A., Maruff, P., Weih, L. A., & Phillips, K. A. (2005). The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature. Brain and Cognition, 59, 60-70. doi:10.1016/j.bandc.2005.05.001
    Ferguson, R. J., Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., & Mott, L. A. (2007). Cognitive-behavioral management of chemotherapy-related cognitive change. Psycho-Oncology, 16, 772-777. doi:10.1002/pon.1133
    Fitch, M. I., Armstrong, J., & Tsang, S. (2008). Patients' experiences with cognitive changes after chemotherapy. Canadian Oncology Nursing Journal, 18, 180-185.
    Galantino, M. L., Brown, D. C., Stricker, C. T., & Farrar, J. T. (2006). Development and testing of a cancer cognition questionnaire. Rehabilitation Oncology, 24, 15-22.
    Hafner, D. L. (2009). Lost in the fog: Understanding "chemobrain." Nursing, 8, 42-45.
    Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., & Munzel, K. (2006). Cognitive function during neoadjuvant chemotherapy for breast cancer. Cancer, 109, 1905-1913.
    Hess, L. M., & Insel, K. C. (2007). Chemotherapy-related change in cognitive function: A conceptual model. Oncology Nursing Forum, 34, 981-994. doi:10.1188/07.ONF.981-994
    Hupcey, J. E., & Penrod, J. (2005). Concept analysis: Examining the state of the science. Research and Theory for Nursing Practice, 19, 197-208.
    Jansen, C. E. (2006). The author responds in Letters to the Editor. Oncology Nursing Forum, 33, 194. doi:10.1188/06.ONF.194
    Jansen, C. E., Dodd, M. J., Miaskowski, C. A., Dowling, G. A., & Kramer, J. (2008). Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide. Psycho-Oncology, 17, 1189-1195. doi:10.1002/pon.1342
    Jansen, C. E., Miaskowski, C. A., Dodd, M. J., & Dowling, G. A. (2005). A critique of the literature on chemotherapy-induced cognitive impairments in women with breast cancer. Oncology Nursing Forum, 32, 329-342. doi:10.1188/05.ONF.329-342
    Jansen, C. E., Miaskowski, C. A., Dodd, M. J., & Dowling, G. A. (2007). A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer. Oncology Nursing Forum, 34, 997-1005. doi:10.1188/07.ONF.997-1005
    Jansen, C. E., Miaskowski, C. A., Dodd, M. J., Dowling, G. A., & Kramer, J. (2005). Potential mechanisms for chemotherapy-induced impairments in cognitive function. Oncology Nursing Forum, 32, 1151-1161. doi:10.1188/05.ONF.1151-1163
    Jim, H. S. L., Donovan, K. A., Small, B. J., Andrykpowsjki, M. A., Munster, P. N., & Jacobsen, P. B. (2009). Cognitive functioning in breast cancer survivors: A controlled comparison. Cancer, 115, 1776-1783.
    Kannarkat, G., Lasher, E. E., & Schiff, D. (2007). Neurologic complications of chemotherapy agents. Current Opinion in Neurology, 20, 719-725.
    Kohli, S., Griggs, J. J., Roscoe, J. A., Jean-Pierre, P., Bole, C., Mustian, K. M., … Morrow, G. R. (2007). Self-reported cognitive impairment in patients with cancer. Journal of Oncology Practice, 3, 54-59.
    Kreukels, B. P. C., van Dam, F. S. A. M., Ridderinkhof, K. R., Boogerd, W., & Schagen, S. B. (2008). Persistent neurocogntive problems after adjuvant chemotherapy for breast cancer. Clinical Breast Cancer, 8, 80-87.
    Lenz, E. R., Pugh, L. C., Milligan, R. A., Gift, A. G., & Suppe. F. (1997). The middle range Theory of Unpleasant Symptoms: An update. Advances in Nursing Science, 19, 14-27.
    Louiselle, C., & Rockhill, J. (2009). Radiation, chemotherapy, and symptom management in cancer-related cognitive dysfunction. Current Pain and Headache Reports, 13, 271-276.
    Mehlsen, M., Pedersen, A. D., Jensen, A. B., & Zachariae, R. (2009). No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy. Psycho-Oncology, 18, 248-257. doi:10.1002/pon.1398
    Mitchell, T. (2007). The social and emotional toll of chemotherapy—Patients' perspectives. European Journal of Cancer Care, 16, 39-47.
    Mulrooney, T. (2008). Cognitive impairment after breast cancer treatment. Clinical Journal of Oncology Nursing, 12, 678-680. doi:10.1188/08.CJON.678-680
    Myers, J. S. (2009a). A comparison of the Theory of Unpleasant Symptoms and the conceptual model of chemotherapy-related changes in cognitive function [Online exclusive]. Oncology Nursing Forum, 36, E1-E10. doi:10.1188/09.ONF.E1-E10
    Myers, J. S. (2009b). Chemotherapy-related cognitive impairment: Neuroimaging, neuropsychological testing, and the neuropsychologist. Clinical Journal of Oncology Nursing, 13, 413-421. doi:10.1188/09.CJON.413-421
    Myers, J. S., Pierce, J., & Pazdernik, T. (2008). Neurotoxicity of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment. Oncology Nursing Forum, 35, 916-920. doi:10.1188/08.ONF.916-920
    Myers, J. S., & Teel, C. (2008). Oncology nurses' awareness of cognitive impairment secondary to chemotherapy. Clinical Journal of Oncology Nursing, 12, 725-729. doi:10.1188/08.CJON.725-729
    Nail, L. M. (2006). Cognitive changes in cancer survivors. American Journal of Nursing, 106, 48-54.
    Nelson, C. J., & Roth, A. J. (2006). Cognitive impairment in patients receiving cancer chemotherapy. Psychiatric Times, 23, 17.
    Oncology Nursing Society. (2009). Oncology Nursing Society 2009-2013 Research Agenda. Retrieved from http://www/
    O'Shaughnessy, J. (2003). Chemotherapy-related cognitive dysfunction in breast cancer. Seminars in Oncology Nursing, 19(Suppl. 2), 17-24. doi:10.1053/S0749-2081(03)00110-4
    Oxman, T. E., & Silberfarb, P. M. (1980). Serial cognitive testing in cancer patients receiving chemotherapy. American Journal of Psychiatry, 137, 1263-1265.
    Pandya, N., & Morris, G. J. (2006). Toxicity of aromatase inhibitors.Seminars in Oncology, 33, 688-695. doi:10.1053/j.seminoncol.2006.08.011
    Paraska, K., & Bender, C. M. (2003). Cognitive dysfunction following adjuvant chemotherapy for breast cancer: Two case studies. Oncology Nursing Forum, 30, 473-478. doi:10.1188/03.ONF.473-478
    Penrod, J., & Hupcey, J. E. (2005a). Concept advancement: Extending science through concept-driven research. Research and Theory for Nursing Practice, 19, 231-241.
    Penrod, J., & Hupcey, J. E. (2005b). Enhancing methodological clarity: Principle-based concept analysis. Journal of Advanced Nursing, 50, 403-409.
    Phillips, K., & Bernhard, J. (2003). Adjuvant breast cancer treatment and cognitive function: Current knowledge and research directions. Journal of the National Cancer Institute, 95, 190-197.
    Raffa, R. B., Duong, P. V., Finney, J., Garber, D. A. Lam, L. M., Mathew, S. S., … Weng, H. F. J. (2006). Is "chemo-fog"/"chemo-brain" caused by cancer chemotherapy? Journal of Clinical Pharmacy and Therapeutics, 31, 129-138.
    Rugo, H. S., & Ahles, T. (2003). The impact of adjuvant therapy for breast cancer on cognitive function: Current evidence and directions for research. Seminars in Oncology, 30, 749-762. doi:10.1053lj.seinoncol.2003.09.008
    Schagen, S. B., Muller, M. J., Boogerd, W., Mellenbergh, G. J., & van Dam, F. S. A. M. (2006). Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients. Journal of the National Cancer Institute, 98, 1742-1745. doi:10.1093/jnci/djj470
    Schagen, S. B., & van Dam, F. S. A. M. (2006). Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect? Journal of Clinical Oncology, 24, 5170-5171. doi:10.1200/JCO.2006.07.8303
    Schagen, S. B., van Dam, F. S. A. M., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999). Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer, 85, 640-650.
    Silberfarb, P. M., Philibert, D., & Levine, P. M. (1980). Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients. American Journal of Psychiatry, 137, 597-601.
    Silverman, D. H. S., Dy, C. J., Castellon, S. A., Lai, J., Pio, B. S., Abraham, L., … Ganz, P. A. (2007). Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Research and Treatment, 103, 303-311. doi:10.1007/s10549-006-9380z
    Simmons, C. C. (2009). Chemo brain, antiestrogens, and me. Clinical Journal of Oncology Nursing, 13, 253-254. doi:10.1188/09.CJON.253-254
    Skinner, J. L. (2009). Cancer treatment related cognitive changes. In M. Polovich, M. Whitford, & M. Olsen (Eds.), Chemotherapy and biotherapy guidelines and recommendations for practice (pp. 284-300). Pittsburgh, PA: Oncology Nursing Society.
    Staat, K., & Segatore, M. (2005). The phenomenon of chemo brain. Clinical Journal of Oncology Nursing, 9, 713-721. doi:10.1188/05.CJON.713-721
    Stewart, A., Collins, B., Mackenzie, J., Tomiak, E., Verma, S., & Bielajew, C. (2008). The cognitive effects of adjuvant chemotherapy in early stage breast cancer: A prospective study. Psycho-Oncology, 17, 122-130. doi:10.1002/pon.1210
    Taillibert, S., Voillery, D., & Bernard-Marty, C. (2007). Chemobrain: Is systemic chemotherapy neurotoxic? Current Opinion in Oncology, 19, 623-627.
    Tannock, I. F., Ahles, T. A., Ganz, P. A., & van Dam, F. S. (2004). Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. Journal of Clinical Oncology, 22, 2233-2239. doi:10.1200/JCO.2004.08.094
    Tchen, N., Juffs, H. G., Downie, F. P., Yi, Q. L., Hu, H., Chemerynsky, I.,… Tannock, I. F. (2003). Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology, 21, 4175-4183. doi:10.1200/JCO.2003.01.119
    Vardy, J., Rourke, S., & Tannock, I. F. (2007). Evaluation of cognitive function associated with chemotherapy: A review of published studies and recommendations for future research. Journal of Clinical Oncology, 25, 2455-2463. doi:10.1200/JCO.2006.08.1604
    Vardy, J., Wefel, J. S., Ahles, T., Tannock, I. F., & Schagen, S. B. (2008). Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Annals of Oncology, 19, 623-629. doi:10.1093/annonc/mdm500
    Vardy, J., Wong, K., Yi, Q. L., Park, A., Maruff, P., Wagner, L., & Tannock, I. F. (2006). Assessing cognitive function in cancer patients. Supportive Care Cancer, 14, 1111-1118. doi:10.1007/s00520-006-0037-6
    von Ah, D., Russell, K. M., Storniolo, A. M., & Carpenter, J. S. (2009). Cognitive dysfunction and its relationship to quality of life in breast cancer survivors. Oncology Nursing Forum, 36, 326-334. doi:10.1188/09.ONF.326-334
    Wefel, J. S., Lenzi, R., Theriault. R. L., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004). "Chemobrain" in breast carcinoma? A prologue. Cancer, 101, 466-475. doi:10.1002/cncr.20272
    Weiss, B. (2008). Chemobrain: A translational challenge for neurotoxicology. Neurtoxicology, 29, 891-898.
    Wieneke, M. H., & Dienst, E. R. (1995). Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology, 4, 61-66.